NCT00093353 · Interventional trial
N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
Overall registry status Completed
Phase 1
Conditions Diarrhea, Drug/Agent Toxicity by Tissue/Organ, Neuroblastoma
Delaware Valley sites
- Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory